» Articles » PMID: 31285287

COPD Beyond Proximal Bronchial Obstruction: Phenotyping and Related Tools at the Bedside

Overview
Journal Eur Respir Rev
Specialty Pulmonary Medicine
Date 2019 Jul 10
PMID 31285287
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by nonreversible proximal bronchial obstruction leading to major respiratory disability. However, patient phenotypes better capture the heterogeneously reported complaints and symptoms of COPD. Recent studies provided evidence that classical bronchial obstruction does not properly reflect respiratory disability, and symptoms now form the new paradigm for assessment of disease severity and guidance of therapeutic strategies. The aim of this review was to explore pathways addressing COPD pathogenesis beyond proximal bronchial obstruction and to highlight innovative and promising tools for phenotyping and bedside assessment. Distal small airways imaging allows quantitative characterisation of emphysema and functional air trapping. Micro-computed tomography and parametric response mapping suggest small airways disease precedes emphysema destruction. Small airways can be assessed functionally using nitrogen washout, probing ventilation at conductive or acinar levels, and forced oscillation technique. These tests may better correlate with respiratory symptoms and may well capture bronchodilation effects beyond proximal obstruction.Knowledge of inflammation-based processes has not provided well-identified targets so far, and eosinophils probably play a minor role. Adaptative immunity or specific small airways secretory protein may provide new therapeutic targets. Pulmonary vasculature is involved in emphysema through capillary loss, microvascular lesions or hypoxia-induced remodelling, thereby impacting respiratory disability.

Citing Articles

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview.

Li L, Zhang C, Zhu F, Zheng G, Liu Y, Liu K Front Pharmacol. 2022; 13:821941.

PMID: 35401201 PMC: 8988065. DOI: 10.3389/fphar.2022.821941.


Adipose triglyceride lipase-mediated lipid catabolism is essential for bronchiolar regeneration.

Kanti M, Striessnig-Bina I, Wieser B, Schauer S, Leitinger G, Eichmann T JCI Insight. 2022; 7(9).

PMID: 35349484 PMC: 9090255. DOI: 10.1172/jci.insight.149438.


Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD.

Ancel J, Belgacemi R, Diabasana Z, Perotin J, Bonnomet A, Dewolf M Diagnostics (Basel). 2021; 11(9).

PMID: 34573921 PMC: 8469815. DOI: 10.3390/diagnostics11091579.


WNT Signalling in Lung Physiology and Pathology.

Hu Y, Ciminieri C, Hu Q, Lehmann M, Konigshoff M, Gosens R Handb Exp Pharmacol. 2021; 269:305-336.

PMID: 34463851 PMC: 8969078. DOI: 10.1007/164_2021_521.


Targeted therapy in eosinophilic chronic obstructive pulmonary disease.

Fieldes M, Bourguignon C, Assou S, Nasri A, Fort A, Vachier I ERJ Open Res. 2021; 7(2).

PMID: 33855061 PMC: 8039900. DOI: 10.1183/23120541.00437-2020.


References
1.
Martinez C, Chen Y, Westgate P, Liu L, Murray S, Curtis J . Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax. 2012; 67(5):399-406. PMC: 3719874. DOI: 10.1136/thoraxjnl-2011-201185. View

2.
Wagner P, Dantzker D, Dueck R, Clausen J, West J . Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest. 1977; 59(2):203-16. PMC: 333349. DOI: 10.1172/JCI108630. View

3.
Levine C, Gewolb I, Allen K, Welch R, Melby J, Pollack S . The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res. 2005; 58(1):15-21. DOI: 10.1203/01.PDR.0000156371.89952.35. View

4.
Papaioannou A, Loukides S, Minas M, Kontogianni K, Bakakos P, Gourgoulianis K . Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers. Respir Res. 2011; 12:67. PMC: 3120669. DOI: 10.1186/1465-9921-12-67. View

5.
Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet P . Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2019; 14:381-389. PMC: 6377046. DOI: 10.2147/COPD.S177638. View